The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines

References

• von Elm E, DG A, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies, BMJ. Available from: 2007;335:806–808. [Internet] http://www.ncbi.nlm.nih.gov/pubmed/18711640%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2034723&tool=pmcentrez&rendertype=abstract
   PubMed Web of Science ®Google Scholar
• EI B, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement, PLoS Med. 2015; 12(10):e1001885.
   Web of Science ®Google Scholar
• Langan SM, Schmidt SA, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE), BMJ. 2018;363:k3532.
   Google Scholar
• Williams RJ, Tse T, Harlan WR, et al. Registration of observational studies: Is it time?, CMAJ. 2010; DOI:10.1503/cmaj.092252
   Web of Science ®Google Scholar
• Loder E, Groves T, MacAuley D. Registration of observational studies. BMJ. 2010;340(feb18 2):c950-c950.
   PubMedGoogle Scholar
• Vora P, Artime E, Soriano-Gabarró M, et al. A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European union electronic register of post-authorization studies, Pharmacoepidemiol Drug Saf. 2018;27(7):695–706.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): A prospective observational study, Lancet Neurol. 2013;12(3):244–252.
   PubMed Web of Science ®Google Scholar
• Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease, Mov Disord. 2010;25(15):2649–2653.
   PubMed Web of Science ®Google Scholar
• Anderson R, Saiers JH, Abram S, et al. Accuracy in equianalgesic dosing: conversion dilemmas, J Pain Symptom Manage. 2001;21(5):p. p. 397–406.
   PubMed Web of Science ®Google Scholar
• Von Korff M, Saunders K, Thomas Ray G, et al. De Facto long-term opioid therapy for noncancer pain, Clin J Pain. 2008;26(4):521-527.
   PubMed Web of Science ®Google Scholar
• Agoritsas T, Merglen A, Shah ND, et al. Adjusted analyses in studies addressing therapy and harm: Users’ guides to the medical literature, JAMA – J Am Med Assoc. 2017;317(7):748-759.
   Web of Science ®Google Scholar
• Mansournia MA, Jewell NP, Greenland S. Case–control matching: effects, misconceptions, and recommendations. Eur J Epidemiol. 2018;33(1):5–14.
   Web of Science ®Google Scholar
• Mansournia MA, Etminan M, Danaei G, et al. Handling time varying confounding in observational research, BMJ. 2017; j4587. 10.1136/bmj.j4587
   PubMedGoogle Scholar
• Mansournia MA, Altman DG. Inverse probability weighting. BMJ. 2016;i189. DOI:10.1136/bmj.i189
   Google Scholar
• Uddin MJ, Groenwold RHH, Ali MS, et al. Methods to control for unmeasured confounding in pharmacoepidemiology: an overview, Int J Clin Pharm. 2016; DOI:10.1007/s11096-016-0299-0
   PubMed Web of Science ®Google Scholar
• Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol. 2008;8(1). DOI:10.1186/1471-2288-8-70
   PubMedGoogle Scholar
• Schisterman EF, Cole SR, Platf RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20(4):488–495.
   PubMed Web of Science ®Google Scholar
• Bandoli G, Palmsten K, Flores KF, et al. Constructing Causal Diagrams for Common Perinatal Outcomes: Benefits, limitations and motivating examples with maternal antidepressant use in pregnancy, Paediatr Perinat Epidemiol. 2016; DOI:10.1111/ppe.12302
   PubMed Web of Science ®Google Scholar
• Park-Wyllie LY, Levine MA, Holbrook A, et al. Outcomes of Dosage Adjustments Used to Manage Antiretroviral Drug Interactions, Clin Infect Dis. 2007; DOI:10.1086/521252
   PubMed Web of Science ®Google Scholar
• Basch E, The missing voice of patients in drug-safety reporting, N Engl J Med. Available from: 2010;362(10):865–869. [Internet] http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:New+engla+nd+journal#0
   PubMed Web of Science ®Google Scholar
• Anderson C, Krska J, Murphy E, et al. The importance of direct patient reporting of suspected adverse drug reactions: A patient perspective, Br J Clin Pharmacol. 2011; DOI:10.1111/j.1365-2125.2011.03990.x
   Web of Science ®Google Scholar
• Stewart M. Towards a global definition of patient centred care. BMJ. 2001. DOI:10.1136/bmj.322.7284.444
   Google Scholar
• Post B, Merkus MP, de Haan RJ, et al. Prognostic factors for the progression of Parkinson’s disease: a systematic review, Mov Disord. [ quiz 1988] 2007;22(13):1839–1851. Available from:
   PubMed Web of Science ®Google Scholar
• Goldfarb DS, Montori V, Devereaux PJ, et al. Patients at the centre: In our practice, and in our use of language (multiple letters), Evid Based Med. 2004;9(2):39–40.
   Google Scholar
• Price A, Schroter S, Snow R, et al. Frequency of reporting on patient and public involvement (PPI) in research studies published in a general medical journal: A descriptive study, BMJ Open. 2018; DOI:10.1136/bmjopen-2017-020452
   Web of Science ®Google Scholar
• Staniszewska S, Brett J, Simera I, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research, BMJ. 2017; DOI:10.1136/bmj.j3453
   PubMedGoogle Scholar
• Xian Y, Wu J, O’Brien EC, et al. Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: Observational analysis from patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study, BMJ. 2015; DOI:10.1136/bmj.h3786
   PubMedGoogle Scholar
• Laubendera RP, Bender R. Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model. Stat Med. 2010. DOI:10.1002/sim.3793
   Web of Science ®Google Scholar
• Mancini GB, Schulzer M. Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure: applications to highly cited trials in cardiovascular medicine. Circulation. 1999;99(3):377–383.
   PubMed Web of Science ®Google Scholar
• Schulzer M, Mancini GB, “Unqualified success” and “unmitigated failure”: number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events, Int J Epidemiol. Available from: 1996;25(4):704–712. [Internet] http://www.ncbi.nlm.nih.gov/pubmed/8921446
   PubMed Web of Science ®Google Scholar
• Zuckerman IH, Langenberg P, Baumgarten M, et al. Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults, Med Care. 2006; DOI:10.1097/01.mlr.0000215849.15769.be
   PubMed Web of Science ®Google Scholar
• Johnson JL, Beaudet A. Sex and gender reporting in health research: Why Canada should be a leader. Can J Public Heal. 2013. DOI:10.1007/BF03405660
   PubMed Web of Science ®Google Scholar
• Springer KW, Mager Stellman J, Jordan-Young RM. Beyond a catalogue of differences: A theoretical frame and good practice guidelines for researching sex/gender in human health. Soc Sci Med. 2012. DOI:10.1016/j.socscimed.2011.05.033
   Web of Science ®Google Scholar
• Hankivsky O, Springer KW, Hunting G. Beyond sex and gender difference in funding and reporting of health research. Res Integr Peer Rev. 2018. DOI:10.1186/s41073-018-0050-6
   PubMedGoogle Scholar
• Soldin PO, Mattison RD. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2009;44:499–523.
   Google Scholar
• Anderson PL, Kakuda TN, Kawle S, et al. Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals, AIDS. 2003; DOI:10.1097/00002030-200310170-00003
   Web of Science ®Google Scholar
• Mellemkjær L, Blot WJ, Sørensen HT, et al. Upper gastrointestinal bleeding among users of NSAIDs: A population-based cohort study in Denmark, Br J Clin Pharmacol. 2002;53(2):173–181.
   PubMed Web of Science ®Google Scholar
• Ozturk S, Kayaalp M, McDonald CJ. Visualization of patient prescription history data in emergency care. AMIA Annu Symp Proc. 2014;2014:963–968.
   PubMedGoogle Scholar
• Phadnis MA, Shireman TI, Wetmore JB, et al. Estimation of Drug Effectiveness by Modeling Three Time-Dependent Covariates: An application to data on cardioprotective medications in the chronic dialysis population, Stat Biopharm Res. 2014;6(3):229–240.
   PubMed Web of Science ®Google Scholar
• Cragg JJ, Tong B, Jutzeler CR, et al. A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury, Neurotherapeutics. 2019;16(3):858–867.
   Web of Science ®Google Scholar
• Edwards JK, Hester LL, Gokhale M, et al. Methodologic Issues when Estimating Risks in Pharmacoepidemiology, Curr Epidemiol Reports. 2016; DOI:10.1007/s40471-016-0089-1
   PubMedGoogle Scholar
• Suissa S, Azoulay L. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care. 2012;35(12):2665–2673.
   PubMed Web of Science ®Google Scholar
• Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol. 2008. DOI:10.1093/aje/kwn135
   Web of Science ®Google Scholar
• Drake I, Gullberg B, Sonestedt E, et al. Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting, Int J Cancer. 2017; DOI:10.1002/ijc.30824
   Web of Science ®Google Scholar
• Raymakers AJN, Sadatsafavi M, Sin DD, et al. The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD: A Population-based cohort study, Chest. 2017; DOI:10.1016/j.chest.2017.02.002
   PubMedGoogle Scholar
• Tsao NW, Lynd LD, Sayre EC, et al. Use of biologics during pregnancy and risk of serious infections in the mother and baby: A Canadian population-based cohort study, BMJ Open. 2019; DOI:10.1136/bmjopen-2018-023714
   Web of Science ®Google Scholar
• Berger ML, Sox H, Willke RJ, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE special task force on real-world evidence in health care decision making, Pharmacoepidemiol Drug Saf. 2017;26(9):1033–1039.
   Web of Science ®Google Scholar
• Benson K, Hartz AJ, A comparison of observational studies and randomized, controlled trials, N Engl J Med. Available from: 2000;342(25):1878–1886. [Internet] http://www.ncbi.nlm.nih.gov/pubmed/10861324
   PubMed Web of Science ®Google Scholar
• Tannen RL, Weiner MG, Xie D. Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings. BMJ. 2009;338:395–399.
   Google Scholar
• Rouch L, Cestac P, Hanon O, et al. Antihypertensive drugs, prevention of cognitive decline and dementia: A systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms, CNS Drugs. 2015;29(2):p. p. 113–130.
   PubMed Web of Science ®Google Scholar
• Altman DG, Simera I, Hoey J, et al. EQUATOR: reporting guidelines for health research, Lancet. 2008;371(9619):1149–1150.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials, BMJ. Available from: 2010;340(mar23 1):698–702. [Internet] http://www.bmj.com/cgi/doi/10.1136/bmj.c332
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. Available from:. 2009;339(jul21 1):b2535–b2535. [Internet] http://www.bmj.com/cgi/doi/10.1136/bmj.b2535
   PubMed Web of Science ®Google Scholar
• Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: Consensus-based clinical case report guideline development, J Clin Epidemiol. 2014;67(1):46–51.
   PubMed Web of Science ®Google Scholar
• O’Brien BC, Harris IB, Beckman TJ, et al. Standards for Reporting Qualitative Research. Acad Med. Available from:. 2014;89(9):1245–1251. [Internet] http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001888-201409000–00021
   PubMed Web of Science ®Google Scholar
• Cohen JF, Korevaar DA, Altman DG, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: Explanation and elaboration. BMJ Open. 2016;6(11):e012799.
   Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and,accurate reporting of studies of diagnostic accuracy: The STARD initiative, Br Med J. 2003;326(7379):41–44.
   PubMed Web of Science ®Google Scholar
• Goodman D, Ogrinc G, Davies L, et al. Explanation and elaboration of the SQUIRE (Standards for Quality Improvement Reporting Excellence) Guidelines, V.2.0: Examples of SQUIRE elements in the healthcare improvement literature, BMJ Qual Saf. 2016;25(12):e 7.
   Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, Eur J Heal Econ. 2013;14(3):367–372.
   PubMed Web of Science ®Google Scholar
• Drummond GB, Paterson DJ, McGrath JC. Animal research: reporting in vivo experiments: The ARRIVE guidelines. Exp Physiol. 2010;95(8):842–844.
   PubMed Web of Science ®Google Scholar
• Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: Defining standard protocol items for clinical trials, Ann Int Med. 2013;158(3):200–207.
   PubMed Web of Science ®Google Scholar
• Brouwers MC, Kerkvliet K, Spithoff K. The AGREE reporting checklist: A tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152.
   PubMedGoogle Scholar
• Vohra S, Shamseer L, Sampson M, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. J Clin Epidemiol. 2016;76:9–17.
   PubMed Web of Science ®Google Scholar
• Gallo V, Egger M, McCormack V, et al. STrengthening the reporting of OBservational studies in epidemiology - molecular epidemiology (STROBE-ME): An extension of the STROBE statement. PLoS Med. 2011;8(10):e1001117.
   Web of Science ®Google Scholar
• Little J, Higgins JPT, Ioannidis JP a, et al. Strengthening the reporting of genetic association studies (STREGA): An extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement, J Clin Epidemiol. Available from: 2009;62(6):597–608.e4. [Internet] http://www.ncbi.nlm.nih.gov/pubmed/19217256
   PubMed Web of Science ®Google Scholar